How Tirzepatide Dosing Differs From Semaglutide Tirzepatide and semaglutide target different receptor pathways, which affects how clinicians approach titration and dosing strategies
There is a known link between Hashimotos and type 2 diabetes, with up to 30 percent of those with Hashimotos developing the condition
16, 2025 (Andrew Caballero-Reynolds/AFP via Getty Images) White House makes new most favored nation deal, shares updates on FDA vouchers, GLP-1 negotiations President Donald Trump announced a sweeping new effort to broaden IVF access by securing massive discounts on fertility drugs from EMD Serono, the latest deal Sign up to read this article for free
The American Diabetes Association's Standards of Medical Care in Diabetes does not list colorectal cancer risk as a consideration when prescribing GLP-1 receptor agonists
This loophole runs through compounding pharmacies, specialized pharmacies that can manufacture one-off and small-batch prescriptions for people with certain allergies to inactive ingredients in brand-name medications